AbbVie Walks Away From CytomX Partnership, But Garnering Attention Of Big Pharma Partners
CytomX Therapeutics Inc (NASDAQ:CTMX) will weigh its options for CX-2029, a CD71-directed antibody-drug conjugate, after AbbVie Inc (NYSE:ABBV) decided…
Japanese Government Urges China To Release Astellas Pharma’s Employee
The Japanese government is reportedly seeking the release of an employee of Japanese pharma company Astellas Pharma Inc (OTC: ALPMF), detained by Chinese authorities.
The reasons why the person was detained are still unknown.
Pfizer, Astellas Tout Positive Xtandi Data To Potentially Expand Label For The Prostate Cancer Drug
Pfizer Inc (NYSE:PFE) and Astellas Pharma Inc (OTC:ALPMY) released topline results from the Phase 3 EMBARK trial evaluating Xtandi (enzalutamide) in non-metastatic hormone-sensitive…
Analyst Says Selecta Biosciences’ Gout Candidate Can Potentially Raise The Bar On Several Fronts
Canaccord Genuity has increased the price target for Selecta Biosciences Inc (NASDAQ:SELB) from $9 to $10 while maintaining the Buy rating ahead of…
Astellas’ Menopause Drug Under FDA Review
The FDA accepted Astellas Pharma Inc’s (OTC:ALPMF) menopause treatment for approval five months after the therapy hit a speed bump in…
Seagen’s Bladder Cancer Trial Data Meets Expectation, Analysts Say
Earlier today, Seagen Inc (NASDAQ:FBI) and Astellas Pharma Inc (OTC:ALPMF) announced topline results from the phase 1b/2 EV-103 trial (KEYNOTE-869) cohort K of Padcev…